Crohn's disease - The Lancet
4.6 (623) · $ 26.50 · In stock
Crohn's disease Nature Reviews Disease Primers
Crohns Disease Diagnostic & Therapeutic Market Size & Share Analysis - Industry Research Report - Growth Trends
Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn's Disease and Ulcerative Colitis
Mycobacterium avium subspecies paratuberculosis and Crohn's disease – Authors' reply - The Lancet Infectious Diseases
Does a mycobacterial infection cause Crohn's disease? - The Lancet Infectious Diseases
Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease - The Lancet
Differentiating crohn's disease from other diseases - wikidoc
Crohn's disease - The Lancet
Lancet Publication suggests link between smoking and relapses in Crohn's disease
:max_bytes(150000):strip_icc()/crohns-disease-diagnosis-5aec9f49c5542e0036b9785c.png)
How Crohn's Disease Is Diagnosed
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study - The Lancet
